KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

BeOne Medicines (ONC) Short-Term Debt issuances (2017 - 2025)

Historic Short-Term Debt issuances for BeOne Medicines (ONC) over the last 7 years, with Q2 2025 value amounting to $141.5 million.

  • BeOne Medicines' Short-Term Debt issuances fell 2240.49% to $141.5 million in Q2 2025 from the same period last year, while for Sep 2025 it was $765.4 million, marking a year-over-year decrease of 703.84%. This contributed to the annual value of $868.3 million for FY2024, which is 3125.18% up from last year.
  • Per BeOne Medicines' latest filing, its Short-Term Debt issuances stood at $141.5 million for Q2 2025, which was down 2240.49% from $80.0 million recorded in Q1 2025.
  • BeOne Medicines' 5-year Short-Term Debt issuances high stood at $543.9 million for Q4 2024, and its period low was $768000.0 during Q3 2023.
  • In the last 5 years, BeOne Medicines' Short-Term Debt issuances had a median value of $99.5 million in 2021 and averaged $144.5 million.
  • Within the past 5 years, the most significant YoY rise in BeOne Medicines' Short-Term Debt issuances was 82031.16% (2023), while the steepest drop was 9920.16% (2023).
  • BeOne Medicines' Short-Term Debt issuances (Quarter) stood at $102.9 million in 2021, then surged by 45.79% to $150.0 million in 2022, then surged by 232.61% to $498.9 million in 2023, then increased by 9.01% to $543.9 million in 2024, then plummeted by 73.98% to $141.5 million in 2025.
  • Its Short-Term Debt issuances stands at $141.5 million for Q2 2025, versus $80.0 million for Q1 2025 and $543.9 million for Q4 2024.